Skip to main content
Livermore
Livermore
ZHEN

Clearstead Advisors, LLC

SEC CIK
0000842775
Latest filing
Aug 6, 2026

GSK holding history

GSK plc in every 13F filed by Clearstead Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
25,921
Value
$1.36M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Clearstead Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202625,921$1.36M<0.1%+11,038+74.2%AddedHolders
Q1 202614,883$821.4K<0.1%−876−5.6%ReducedHolders
Q4 202515,759$772.8K<0.1%−691−4.2%ReducedHolders
Q3 202516,450$710.0K<0.1%+170+1.0%AddedHolders
Q2 202516,280$625.2K<0.1%−26−0.2%ReducedHolders
Q1 202516,306$631.7K<0.1%−901−5.2%ReducedHolders
Q4 202417,207$581.9K<0.1%−665−3.7%ReducedHolders
Q3 202417,872$730.6K<0.1%−559−3.0%ReducedHolders
Q2 202418,431$709.6K<0.1%+10,925+145.6%AddedHolders
Q1 20247,506$339.0K<0.1%−168−2.2%ReducedHolders
Q4 20237,674$284.4K<0.1%+252+3.4%AddedHolders
Q3 20237,422$269.0K<0.1%−566−7.1%ReducedHolders
Q2 20237,988$284.7K<0.1%+1,818+29.5%AddedHolders
Q1 20236,170$219.5K<0.1%+2,575+71.6%AddedHolders
Q4 20223,595$126.3K<0.1%−609−14.5%ReducedHolders
Q3 20224,204$124.0K<0.1%−2,459−36.9%ReducedHolders
Q2 20226,663$290.0K<0.1%+1,737+35.3%AddedHolders
Q1 20224,926$215.0K<0.1%+388+8.6%AddedHolders
Q4 20214,538$200.0K<0.1%−3,920−46.3%ReducedHolders
Q3 20218,458$323.0K<0.1%+1,584+23.0%AddedHolders
Q2 20216,874$274.0K<0.1%+4,192+156.3%AddedHolders
Q1 20212,682$96.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.